797 / 1631
Conclusions
•
Immunochemotherapy has changed the clinical course of NHL
•
Although there is much interest in chemotherapy free options,
these are not without toxicity…chemotherapy is not dead
•
Dose intensified therapies continue to have a role
•
Allogeneic transplantation has only a limited role in NHL
•
Much excitement about CAR-T, but minimal data…limited
applicability